A new oral weight-loss drug from Pfizer could be more effective than the popular Ozempic injection, based on clinical trial results.
Share:
More In Business
J&J, Goldman Sachs Post Quarterly Earnings, Beating Street Estimates
Johnson and Johnson and Goldman Sachs both reported earnings that topped Wall Street estimates.
Stocks Fall Amid Renewed Fears Over Rate Hikes
Stocks fell at the open Tuesday as the 10-year Treasury yield spiked following retail sales data and bank earnings, raising concerns over more rate hikes. Investors are also keeping an eye on tensions in the Middle East and its potential effect on global markets.
LinkedIn Lays Off Nearly 700 Workers
LinkedIn Lays Off Nearly 700 Workers
Stretching Your Dollar: Ways to Start Saving for Holiday Shopping
Saving money on your holiday shopping purchases.
Stretching Your Dollar: Apps to Help Save You Money on Food
How to save money when ordering takeout.
Pfizer Cuts Earnings and Revenue Projections
Pfizer Cuts Earnings and Revenue Projections
Mortgage Costs Surge Make Renting Cheaper
Mortgage Costs Surge Make Renting Cheaper
Earnings on Tap for This Week
Earnings on Tap for This Week
Rite Aid Files for Bankruptcy
Rite Aid Files for Bankruptcy
